Loading
Latest filing published 26 Feb 2025 for Gland Pharma Limited, €17k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
S Srinivasa Rao, listed as chief executive, appears in our data through filings on Gland Pharma Limited shares, published by SEBI (PIT + SAST). The record holds 21 filings, for trades running from 25 May 2021 to 26 February 2025.
Sales make up the whole of the open-market record (19 sales, €571k). Other entries cover 2 share grants.
The latest filing, published on 26 February 2025, reports a share grant of €17k in Gland Pharma Limited. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations